Constitutive activation of the neurotensin receptor 1 by mutation of Phe358 in Helix seven

被引:31
作者
Barroso, S [1 ]
Richard, F [1 ]
Nicolas-Ethève, D [1 ]
Kitabgi, P [1 ]
Labbé-Jullié, C [1 ]
机构
[1] Univ Nice, CNRS, Inst Pharmacol Mol & Cellulaire, UMR 6097, F-06560 Valbonne, France
关键词
neurotensin; NTS1; G protein-coupled receptor; constitutive activity; mutation;
D O I
10.1038/sj.bjp.0704546
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 The neurotensin receptor 1, NTS1, is a G protein-coupled receptor with seven transmembrane domains (TM) that mediates most of the known effects of the neuropeptide. Our previous studies have pointed to extracellular loop 3 and adjacent TM7 as being potentially involved in agonist-induced activation of the NTS1. 2 Here we investigated residues in these domains that might be involved in transconformational activation of the rat NTS1. Single amino acid mutated receptors were expressed in COS cells and inositol phosphate (IP) and cyclic AMP productions were studied. 3 The F358A mutation in TM7 resulted in a time- and receptor concentration-dependent increase in spontaneous IP production. At expression levels of 12 pmol mg(-1), agonist-independent IP production was increased 10 fold over basal for the F358A mutant receptor whereas the wild type NTS1 exhibited virtually no spontaneous activity at expression levels of 7.5 pmol mg(-1). 4 Neurotensin remained agonist on the F358A mutant receptor with a maximal effect that amounted to greater than twice basal IP levels. SR 48692 was inverse agonist at the mutant receptor, reversing IP production almost back to the levels measured in wild type NTS1-transfected cells. 5 Cyclic AMP production was not constitutively activated with the F358A mutant receptor but was stimulated by neurotensin with the same concentration dependence as that observed with the wild type NTS1. 6 This is the first report, to our knowledge, of a constitutively active mutant of the NTS1. The data are consistent with TM7 being involved in the transconformational changes that lead to agonistinduced coupling of the NTS1 to Gq.
引用
收藏
页码:997 / 1002
页数:6
相关论文
共 31 条
[1]   Identification of residues involved in neurotensin binding and modeling of the agonist binding site in neurotensin receptor 1 [J].
Barroso, S ;
Richard, F ;
Nicolas-Ethève, D ;
Reversat, JL ;
Bernassau, JM ;
Kitabgi, P ;
Labbé-Jullié, C .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (01) :328-336
[2]   Constitutive activation of the δ opioid receptor by mutations in transmembrane domains III and VII [J].
Befort, K ;
Zilliox, C ;
Filliol, D ;
Yue, SY ;
Kieffer, BL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (26) :18574-18581
[3]   IMMUNOLOGICAL AND BIOCHEMICAL-CHARACTERIZATION OF PROCESSING PRODUCTS FROM THE NEUROTENSIN NEUROMEDIN-N PRECURSOR IN THE RAT MEDULLARY-THYROID CARCINOMA-6-23 CELL-LINE [J].
BIDARD, JN ;
DENADAI, F ;
ROVERE, C ;
MOINIER, D ;
LAUR, J ;
MARTINEZ, J ;
CUBER, JC ;
KITABGI, P .
BIOCHEMICAL JOURNAL, 1993, 291 :225-233
[4]   Pharmacology of muscarinic receptor subtypes constitutively activated by G proteins [J].
Burstein, ES ;
Spalding, TA ;
Brann, MR .
MOLECULAR PHARMACOLOGY, 1997, 51 (02) :312-319
[5]  
CHIDIAC P, 1994, MOL PHARMACOL, V45, P490
[6]   Human calcitonin receptors exhibit agonist-independent (constitutive) signaling activity [J].
Cohen, DP ;
Thaw, CN ;
Varma, A ;
Gershengorn, MC ;
Nussenzveig, DR .
ENDOCRINOLOGY, 1997, 138 (04) :1400-1405
[7]   MECHANISM OF ACTIVATION AND INACTIVATION OF OPSIN - ROLE OF GLU(113) AND LYS(296) [J].
COHEN, GB ;
OPRIAN, DD ;
ROBINSON, PR .
BIOCHEMISTRY, 1992, 31 (50) :12592-12601
[8]   Requirement of rigid-body motion of transmembrane helices for light activation of rhodopsin [J].
Farrens, DL ;
Altenbach, C ;
Yang, K ;
Hubbell, WL ;
Khorana, HG .
SCIENCE, 1996, 274 (5288) :768-770
[9]   Constitutive activation of the human vasoactive intestinal peptide 1 receptor, a member of the new class II family of G protein-coupled receptors [J].
Gaudin, P ;
Maoret, JJ ;
Couvineau, A ;
Rouyer-Fessard, C ;
Laburthe, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (09) :4990-4996
[10]   Agonists induce conformational changes in transmembrane domains III and VI of the beta(2) adrenoceptor [J].
Gether, U ;
Lin, S ;
Ghanouni, P ;
Ballesteros, JA ;
Weinstein, H ;
Kobilka, BK .
EMBO JOURNAL, 1997, 16 (22) :6737-6747